{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:08:05Z","timestamp":1777608485915,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.atherosclerosis.2011.07.009","type":"journal-article","created":{"date-parts":[[2011,7,24]],"date-time":"2011-07-24T15:49:13Z","timestamp":1311522553000},"page":"411-415","source":"Crossref","is-referenced-by-count":10,"title":["The Fc\u03b3 receptor IIA R131H gene polymorphism is associated with endothelial function in patients with hypercholesterolaemia"],"prefix":"10.1016","volume":"218","author":[{"given":"Markus P.","family":"Schneider","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanette H.W.","family":"Leusen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph D.","family":"Garlichs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Amann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"John","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland E.","family":"Schmieder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2011.07.009_bib0005","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri2206","article-title":"Fcgamma receptors as regulators of immune responses","volume":"8","author":"Nimmerjahn","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.atherosclerosis.2011.07.009_bib0010","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.imlet.2006.09.008","article-title":"Anti-OxLDL IgG blocks OxLDL interaction with CD36, but promotes FcgammaR, CD32A-dependent inflammatory cell adhesion","volume":"108","author":"Nagarajan","year":"2007","journal-title":"Immunol Lett"},{"key":"10.1016\/j.atherosclerosis.2011.07.009_bib0015","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0021-9150(97)00157-3","article-title":"The uptake of LDL-IC by human macrophages: predominant involvement of the Fc gamma RI receptor","volume":"135","author":"Lopes-Virella","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2011.07.009_bib0020","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1084\/jem.190.4.585","article-title":"The major receptor for C-reactive protein on leukocytes is fcgamma receptor II","volume":"190","author":"Bharadwaj","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.atherosclerosis.2011.07.009_bib0025","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/nature07468","article-title":"Structural recognition and functional activation of FcgammaR by innate pentraxins","volume":"456","author":"Lu","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2011.07.009_bib0030","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1161\/01.ATV.0000241572.05292.fb","article-title":"C-reactive protein decreases interleukin-10 secretion in activated human monocyte-derived macrophages via inhibition of cyclic AMP production","volume":"26","author":"Singh","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2011.07.009_bib0035","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.yjmcc.2007.08.015","article-title":"C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling","volume":"43","author":"Singh","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.atherosclerosis.2011.07.009_bib0040","doi-asserted-by":"crossref","first-page":"H1170","DOI":"10.1152\/ajpheart.00150.2006","article-title":"CRP promotes monocyte-endothelial cell adhesion via Fcgamma receptors in human aortic endothelial cells under static and shear flow conditions","volume":"291","author":"Devaraj","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.atherosclerosis.2011.07.009_bib0045","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1161\/01.ATV.0000168573.10844.ae","article-title":"Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects","volume":"25","author":"Devaraj","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2011.07.009_bib0050","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/cvr\/cvp249","article-title":"C-reactive protein impairs the endothelial glycocalyx resulting in endothelial dysfunction","volume":"84","author":"Devaraj","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2011.07.009_bib0055","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1373\/clinchem.2009.142364","article-title":"C-reactive protein adversely alters the protein-protein interaction of the endothelial isoform of nitric oxide synthase","volume":"56","author":"Valleggi","year":"2010","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2011.07.009_bib0060","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.4049\/jimmunol.147.4.1338","article-title":"A single amino acid in the second Ig-like domain of the human Fc gamma receptor II is critical for human IgG2 binding","volume":"147","author":"Warmerdam","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.atherosclerosis.2011.07.009_bib0065","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1172\/JCI7817","article-title":"C-reactive protein binding to FcgammaRIIa on human monocytes and neutrophils is allele-specific","volume":"105","author":"Stein","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2011.07.009_bib0070","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0735-1097(01)01128-7","article-title":"Rapid improvement of nitric oxide bioavailability after lipid-lowering therapy with cerivastatin within two weeks","volume":"37","author":"John","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2011.07.009_bib0075","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ahj.2004.06.027","article-title":"Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients","volume":"149","author":"John","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.atherosclerosis.2011.07.009_bib0080","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.atherosclerosis.2003.11.004","article-title":"Fluvastatin inhibits raft dependent Fcgamma receptor signalling in human monocytes","volume":"172","author":"Hillyard","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2011.07.009_bib0085","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.4049\/jimmunol.143.5.1731","article-title":"Molecular basis for a polymorphism involving Fc receptor II on human monocytes","volume":"143","author":"Clark","year":"1989","journal-title":"J Immunol"},{"key":"10.1016\/j.atherosclerosis.2011.07.009_bib0090","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1160\/TH04-05-0268","article-title":"Genetic variation in Fcgamma receptor IIa protects against advanced peripheral atherosclerosis. The Rotterdam Study","volume":"92","author":"van der Meer","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2011.07.009_bib0095","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1089\/gtmb.2010.0108","article-title":"The association between a common FCGR2A polymorphism and C-reactive protein and coronary artery disease revisited","volume":"14","author":"Kroupis","year":"2010","journal-title":"Genet Test Mol Biomarkers"},{"key":"10.1016\/j.atherosclerosis.2011.07.009_bib0100","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.atherosclerosis.2009.01.013","article-title":"FcgammaRIIa genotype is associated with acute coronary syndromes as first manifestation of coronary artery disease","volume":"205","author":"Raaz","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2011.07.009_bib0105","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.atherosclerosis.2004.12.011","article-title":"Fcgamma receptor IIIA polymorphism as a risk-factor for coronary artery disease","volume":"180","author":"Gavasso","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2011.07.009_bib0110","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1160\/TH06-08-0467","article-title":"C-reactive protein and Fc gamma RIIa functional polymorphisms are not associated with clinical presentation of stable and unstable angina","volume":"97","author":"Murphy","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2011.07.009_bib0115","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2350-10-46","article-title":"Genetic variation in Fc gamma receptor IIa and risk of coronary heart disease: negative results from two large independent populations","volume":"10","author":"Karakas","year":"2009","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.atherosclerosis.2011.07.009_bib0120","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0140-6736(89)91013-1","article-title":"Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man","volume":"2","author":"Vallance","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2011.07.009_bib0125","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/HYPERTENSIONAHA.110.157354","article-title":"Cardiovascular consequences of genetic variation at \u22126\/235 in human angiotensinogen using humanized gene-targeted mice","volume":"56","author":"Grobe","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2011.07.009_bib0130","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nature04672","article-title":"Targeting C-reactive protein for the treatment of cardiovascular disease","volume":"440","author":"Pepys","year":"2006","journal-title":"Nature"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915011005880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915011005880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T08:35:14Z","timestamp":1686213314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915011005880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0021915011005880"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.07.009","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}